Loading data
CDXSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 70.39 m USD | 59.35 m USD | 70.14 m USD | 138.59 m USD | 104.75 m USD |
| Cost of revenue | 9.34 m USD | 16.29 m USD | 12.81 m USD | 38.03 m USD | 22.21 m USD |
| Research and development expense | 52.31 m USD | 46.26 m USD | 58.89 m USD | 80.1 m USD | 55.92 m USD |
| Selling, general and administrative expense | 47.07 m USD | 55.15 m USD | 53.25 m USD | 52.17 m USD | 49.32 m USD |
| Operating profit | -41.74 m USD | -58.52 m USD | -68.07 m USD | -34.88 m USD | -22.7 m USD |
| Profit before tax | -43.93 m USD | -65.24 m USD | -76.17 m USD | -33.32 m USD | -21.09 m USD |
| Income tax expense | 47 k USD | 34 k USD | 69 k USD | 276 k USD | 189 k USD |
| Net income (reported basis) | -43.97 m USD | -65.28 m USD | -76.24 m USD | -33.59 m USD | -21.28 m USD |
| Basic earnings per share | -0.5 USD/share | -0.89 USD/share | -1.12 USD/share | -0.51 USD/share | -0.33 USD/share |
| Diluted earnings per share | -0.5 USD/share | -0.89 USD/share | -1.12 USD/share | -0.51 USD/share | -0.33 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.